Company / Operating Income per Share
Whitehawk Therapeutics, Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.73
FY2025
5-year range
-$44.49 / -$1.00
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 8 years, ranging from $-44.49 in FY2022 to $-0.28 in FY2019.
Based on SEC 10-K filings.
-2.73 in FY2025.
Declined from $-2.57 to $-2.73 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 6.7% year-over-year.
- Peak operating income per share was recorded in FY2019.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.73 | +6.7% |
| FY2024 | -$2.93 | -14.2% |
| FY2023 | -$2.57 | +94.2% |
| FY2022 | -$44.49 | -4337.1% |
| FY2021 | -$1.00 | -66.5% |
| FY2020 | -$0.60 | -118.6% |
| FY2019 | -$0.28 | +65.1% |
| FY2018 | -$0.79 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026